Abstract
Fenoterol and isoproterenol metered-dose inhalers were compared in 30 asthmatic patients by a double-blind, parallel-group study. FEV1 and FEF 25-75% values recorded after single doses on days 1, 45 and 90 of a three-month continuous treatment period showed that mean increases over baseline were significantly greater and lasted longer with fenoterol.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Adolescent
-
Adult
-
Aerosols
-
Asthma / drug therapy*
-
Blood Pressure / drug effects
-
Drug Evaluation
-
Ethanolamines / therapeutic use*
-
Female
-
Fenoterol / adverse effects
-
Fenoterol / therapeutic use*
-
Forced Expiratory Volume
-
Humans
-
Isoproterenol / adverse effects
-
Isoproterenol / therapeutic use
-
Male
-
Maximal Midexpiratory Flow Rate
-
Middle Aged
-
Pulse / drug effects
Substances
-
Aerosols
-
Ethanolamines
-
Fenoterol
-
Isoproterenol